CATEcast - O Podcast da Cardiologia Intervencionista CardioInterv MaterDei

No episódio dessa semana, Dr. Lucas Lodi, Dr. Fernando Gusmão e Dr. Guilherme Athayde conversam sobre o tratamento percutâneo nas doenças da valva mitral.



Instagram: @cardiointervmaterdei

Facebook: www.facebook.com/CardioIntervMaterDei

Site: cardiointervmaterdei.com.br

Referências:

1. ALCICI, MARTA EUGENIA ; LODI-JUNQUEIRA, LUCAS; SANT’ANNA ATHAYDE, GUILHERME RAFAEL ; et al. The Importance of Conscious Sedation for Life-Saving Valve Procedures in Patients With Rheumatic Heart Disease From Low- to Middle-Income Countries. GLOBAL HEART, v. 14, p. 311-316, 2019.

2. ATHAYDE, GUILHERME RAFAEL SANT'ANNA ; ELMARIAH, SAMMY ; LODI-JUNQUEIRA, LUCAS ; et al. Impact of left atrial compliance improvement on functional status after percutaneous mitral valvuloplasty. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, v. 96, p. 156-163, 2019.

3. ESTEVES, WILLIAM ANTONIO M. ; LODI-JUNQUEIRA, LUCAS; SOARES, JULIANA RODRIGUES ; SANT'ANNA ATHAYDE, GUILHERME RAFAEL ; et al. Impact of percutaneous mitral valvuloplasty on left ventricular function in patients with mitral stenosis assessed by 3D echocardiography. INTERNATIONAL JOURNAL OF CARDIOLOGY, v. 248, p. 280-285, 2017.

4. NUNES, MARIA CARMO P ; NASCIMENTO, BRUNO RAMOS ; LODI-JUNQUEIRA, LUCAS ; TAN, TIMOTHY C ; ATHAYDE, GUILHERME RAFAEL SANT'ANNA; Hung, Judy . Update on percutaneous mitral commissurotomy. HEART, v. 102, p. 500-507, 2016.

5. ESTEVES, WILLIAM A. M. ; LODI-JUNQUEIRA, LUCAS ; NETO, CIRILO P. FONSECA ; et al. The Impact of Right Ventricular Stroke Work on B-Type Natriuretic Peptide Levels in Patients With Mitral Stenosis Undergoing Percutaneous Mitral Valvuloplasty. JOURNAL OF INTERVENTIONAL CARDIOLOGY, v. Epub, p. n/a-n/a, 2013.

6. NUNES, M. C. P. ; HUNG, J. ; BARBOSA, M. M. ; ESTEVES, W. A. ; CARVALHO, V. T. ; LODI-JUNQUEIRA, LUCAS; et al. . Impact of Net Atrioventricular Compliance on Clinical Outcome in Mitral Stenosis. CIRCULATION CARDIOVASCULAR IMAGING, v. 6, p. 1001-1008, 2013.

7. SILVA, VICENTE R. ; NEVES, EULA G. A. ; PASSOS, LÍVIA S. ARAÚJO ; CRISTINA DE MELO, FLÁVIA ; TEIXEIRA-CARVALHO, ANDREA ; NASSIF, MARIA CECÍLIA L. ; LODI-JUNQUEIRA, L ; et al. Decreased Cytokine Plasma Levels and Changes in T-Cell Activation Are Associated With Hemodynamic Improvement and Clinical Outcomes After Percutaneous Mitral Commissurotomy in Patients With Rheumatic Mitral Stenosis. Frontiers in Cardiovascular Medicine, v. 7, p. 1-9, 2021.

8. NUNES, MARIA CARMO P. ; LEVINE, ROBERT A. ; BRAULIO, RENATO ; PASCOAL-XAVIER, MARCELO A. ; ELMARIAH, SAMMY ; GOMES, NAYANA F.A. ; SOARES, JULIANA R. ; ESTEVES, WILLIAM A.M. ; ZENG, XIN ; DAL-BIANCO, JACOB P. ; PASSOS, LIVIA S.A. ; PASSAGLIA, LUIZ G. ; RIBEIRO, VICTOR T. ; GELAPE, CLÁUDIO L. ; COSTA, PAULO H.N. ; LODI-JUNQUEIRA, L ; et al. Mitral Regurgitation After Percutaneous Mitral Valvuloplasty. JACC-Cardiovascular Imaging, v. 13, p. 2513-2526, 2020.

Nessa semana, Dr. Lucas Lodi, Dr. Fernando Gusmão e Dr. Guilherme Athayde conversam e tiram todas as suas dúvidas sobre a Intervenção na estenose aórtica. 

Instagram: @cardiointervmaterdei

Facebook: www.facebook.com/CardioIntervMaterDei

Site: cardiointervmaterdei.com.br

Referências:

1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, SundtTM III, Thomas JD. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:e57–185.

2. Otto CM, Kumbhani DJ, Alexander KP, Calhoon JH, Desai MY, Kaul S, Lee JC, Ruiz CE, Vassileva CM. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardio 2017;69:1313–46.

3. Martin AK, Mohananey D, Ranka S, Riha H, Núñez-Gil IJ, Ramakrishna H. 2017 ESC/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J (2017) 38, 2739–2791.

4. Tarasoutchi Flavio, Montera Marcelo Westerlund, Ramos Auristela Isabel de Oliveira, Sampaio Roney Orismar, Rosa Vitor Emer Egypto, Accorsi Tarso Augusto Duenhas et al . Atualização das Diretrizes Brasileiras de Valvopatias: Abordagem das Lesões Anatomicamente Importantes. Arq. Bras. Cardiol. [Internet]. 2017 [cited 2019 Nov 18] ; 109( 6 Suppl 2 ): 1-34.

5. Kang DH, Park SJ, Lee SA, Lee S, Kim DH, Kim HK, Yun SC, Hong GR, Song JM, Chung CH, Song JK, Lee JW, Park SW. Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis. N Eng J Med 2020 Jan 9;382(2).

Você sabe quais são as vantagens do procedimento por via radial? Nesse episódio, Dr. Lucas Lodi, Dr. Fernando Gusmão e Dr. Guilherme Athayde tiram todas as suas dúvidas!

Instagram: @cardiointervmaterdei

Facebook: www.facebook.com/CardioIntervMaterDei

Site: cardiointervmaterdei.com.br

Referências:

1. Chiarito M, Cao D, Nicolas J, Roumeliotis A, Power D, Chandiramani R, Sartori S, Camaj A, Goel R, Claessen BE, Stefanini GG, Mehran R, Dangas G. Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials. Catheter Cardiovasc Interv. 2021 Jan 28. doi: 10.1002/ccd.29486.

2. Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, Budaj A, Niemelä M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR; RIVAL trial group. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011 Apr 23;377(9775):1409-20. doi: 10.1016/S0140-6736(11)60404-2.

3. Valgimigli M, Frigoli E, Leonardi S, Vranckx P, Rothenbühler M, Tebaldi M, Varbella F, Calabrò P, Garducci S, Rubartelli P, Briguori C, Andó G, Ferrario M, Limbruno U, Garbo R, Sganzerla P, Russo F, Nazzaro M, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Ferrante G, Santarelli A, Sardella G, de Cesare N, Tosi P, van 't Hof A, Omerovic E, Brugaletta S, Windecker S, Heg D, Jüni P; MATRIX Investigators. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial. Lancet. 2018 Sep 8;392(10150):835-848. doi: 10.1016/S0140-6736(18)31714-8. Epub 2018 Aug 25. PMID: 30153988.

No episódio dessa semana, Dr. Lucas Lodi, Dr. Fernando Gusmão e Dr. Guilherme Athayde discutem sobre as orientações gerais sobre os procedimentos endovasculares. 

Instagram: @cardiointervmaterdei

Facebook: www.facebook.com/CardioIntervMaterDei

Site: cardiointervmaterdei.com.br

Referências:

1. ACT Investigators. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation. 2011 Sep 13;124(11):1250-9. doi:10.1161/CIRCULATIONAHA.111.038943.

2. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. N Engl J Med 2018; 378:603-614 DOI: 10.1056/NEJMoa1710933